Open Study Summaries – Pancreatic Cancer

Please consult with your physician or contact the cancer research office at 757-388-2840.

Pancreatic Cancer 

RTOG 0848 – A Phase III Trial Evaluating both Erlotinib And Chemoradiation as Adjuvant Treatment for Patients with Resected Head of Pancreas Adenocarcinoma (NRG)

{{moduleTitle}}